18 studies found for:    diabetes and eye and open and active | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: LSG;   Drug: CMT
2 Unknown  Influence of Acupuncture to Ocular Microcirculation in Patients With Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Procedure: acupuncture
3 Unknown  Doppler Ultrasound Investigation of Microcirculations
Condition: Type 1 Diabetes Mellitus
Interventions: Other: Administration ofOxygen and carbon dioxide;   Other: Administration of Oxygen and carbon dioxide
4 Unknown  Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
Condition: Complications of Diabetes Mellitus
Intervention: Drug: Intravitreal Avastin injection
5 Recruiting PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs
Conditions: DIABETES;   DIABETIC RETINOPATHY;   DIABETIC NEUROPATHY
Intervention: Drug: CHOLESTYRAMINE
6 Unknown  Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
Condition: Diabetes
Interventions: Drug: Actos (Pioglitazone);   Drug: Acarbose
7 Recruiting Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Condition: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: Ranibizumab;   Procedure: Laser photocoagulation;   Procedure: Ranibizumab & laser photocoagulation
8 Recruiting Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
Condition: Diabetic Macular Oedema
Interventions: Device: Noctura 400 Eye Mask;   Drug: Ranibizumab
9 Recruiting Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
Conditions: Visual Acuity Reduced Transiently;   Macular Edema, Cystoid
Intervention: Drug: ranibizumab
10 Unknown  Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
11 Not yet recruiting Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
Condition: Diabetic Macular Edema
Interventions: Drug: Tocilizumab;   Drug: Ranibizumab
12 Unknown  Efficacy Study of Diabetes Group Visits
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Group Visits
13 Recruiting Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
Conditions: Neovascularization;   Macular Degeneration;   Diabetic Retinopathy;   Retinal Vein Occlusion;   Choroidal Neovascularization;   Retinal Neovascularization;   Recurrent Pterygium;   Cystoid Macular Edema
Intervention: Drug: ziv-aflibercept
14 Recruiting Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best Medicine
Condition: Diabetic Kidney Disease
Interventions: Procedure: Optimal medical treatment and surgery;   Procedure: Optimal medical treatment
15 Recruiting PRP vs Bevacizumab for PDR Treatment
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Bevacizumab;   Procedure: Panretinal photocoagulation
16 Recruiting Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
Condition: Diabetic Macular Oedema
Interventions: Device: Navigated laser;   Device: Conventional laser
17 Recruiting Variable Interval Versus Set Interval Aflibercept for DME
Conditions: Cystoid Macular Edema;   Diabetic Macular Edema
Intervention: Drug: Intravitreal Aflibercept Injection
18 Recruiting Analysis of Aqueous and Vitreous Humor
Conditions: Proliferative Diabetic Retinopathy;   Macular Degeneration;   Macular Hole;   Neovascular Glaucoma
Interventions: Drug: Ranibizumab;   Other: No Ranibizumab

Indicates status has not been verified in more than two years